ELIZABETH RAMIREZ: Open Payments
NPI 1407525777 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$946 in 40 payments from 15 companies in 2025. Trend: 2023 $67 · 2024 $411 · 2025 $946
Food & beverage: $946
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $225 |
| AstraZeneca Pharmaceuticals LP | 5 | $154 |
| Echosens North America, Inc. | 1 | $109 |
| Lilly USA, LLC | 5 | $90 |
| Axsome Therapeutics, Inc. | 1 | $85 |
| Eisai Inc. | 2 | $47 |
| Astellas Pharma US Inc | 3 | $44 |
| ABBVIE INC. | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $33 |
| Currax Pharmaceuticals LLC | 2 | $33 |
Products named: Wegovy, AIRSUPRA, Fibroscan, MOUNJARO, Symbravo, Leqembi, Veozah, Ozempic.
Industry payments across TX — which companies pay providers there.
